Skip to main content
SpringerLink
Log in

The down-regulation of IL-6-stimulated fibrinogen steady state mRNA and protein levels by human recombinant IL-1 is not PGE2-dependent: Effects of IL-1 receptor antagonist (IL-1RA)

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Infections, trauma and inflammatory processes induce a host response with increases in a large group of structurally and functionally diverse plasma proteins. Parental administration of foreign proteins also induce an increase in plasma fibrinogen. Interleukin-6 (IL-6) is a monocyte-derived mediator and has regulatory effects on acute phase protein genes which result in the induction of fibrinogen synthesis in primary hepatocytes, while the addition of interleukin-1 (IL-1) exerts a negative modulating influence on the IL-6-stimulated fibrinogen. In order to understand the mechanisms by which IL-1 inhibits IL-6-stimulated fibrinogen transcription and translation, and since IL-1 is believed to act through PGE2 stimulation, we have studied the influence of PGE2 in IL-6 or IL-1, alone and in combination, on Fg mRNA expression (by Northern blot analysis) and the influence of PGE2, indomethacin, and arachidonic acid on Fg secretion. Moreover, since human recombinant interleukin-1 receptor antagonist (hrIL-1ra) is a strong inhibitor of IL-1 induced IL-1 transcription and translation and has an inhibitory effect on PGE2, we have studied the effects of IL-1ra on the down-regulation of IL-6 stimulated fibrinogen by IL-1, using an Fg ELISA method.

Herein we show that using human Hep 3B hepatoma cell cultures, steady-state levels of Fg mRNA is strongly increased in cells treated with IL-6 (10 ng/ml) and IL-6 (10 ng/ml)+PGE2 (5×10−6 M) compared to the control (Nil), while when IL-1 (1 ng/ml) was given in combination with IL-6 10 ng/ml, a strong inhibitory effect was found compared to IL-6 alone. The results were not statistically different from the controls. The addition of PGE2 at 5×10−6 M plus IL-6 10 ng/ml to the cell cultures induced an augmentation of Fg mRNA compared to IL-6 alone.

Hep 3B hepatoma cells treated with IL-6, but not IL-1, induced an increase of Fg secretion compared to the control, while cells treated with the combination IL-6+IL-1 produced the same amounts of Fg compared to the control. The addition of PGE2 to IL-6 alone or IL-1+IL-6 did not modify the results. Arachidonic acid also had no effect on the combination IL-1 + IL-6. Similar results were obtained when indomethacin (5–50 μM) was used. When human recombinant IL-1 receptor antagonist (hrIL-1ra) 1–50 μg/ml was added to the Hep 3B hepatoma cell cultures, a dose-response restoration occured on IL-1-inhibited IL-6-stimulated Fg secretion.

In these studies we show for the first time that PGE2 is not involved in the inhibition induced by IL-1 on IL-6 gene expression and secretion and that PGE2 (5×10−6 and 5×10−7 M) enhances IL-6-stimulation of Fg expression. Moreover, hrIL-1ra restored the down-regulation produced by IL-1 on IL-6-stimulated Fg translation. These results provide additional biological activities for IL-1, suggesting new and different mechanism(s) of action.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

hr:

human recombinant

IL:

interleukin

PGE2:

prostaglandin E2

Indo:

indomethacin

NDGA:

nordihydroguaiaretic acid

AA:

arachidonic acid

References

  1. Balavoine JF, de Rochemonteix B, Williamson K, Seckinger P, Cruchand, Dayer J-M: Prostaglandin E2 and collagenase production by fibroblasts and synovial cells is regulated by Urine-derived human interleukin-1 and inhibitor(s). J Clin Invest 78, 1120–1124, 1986

    PubMed  Google Scholar 

  2. Baracos V, Rodemann HP, Dinarello CA, Goldberg AL: Stimulation of muscle protein degradation and prostaglandin E2 release by leukocytic pyrogen (interleukin-1). N Engl J Med 308:553–558, 1983

    PubMed  Google Scholar 

  3. Bauman H, Gauldie J: Regulation of hepatic acute phase plasma protein genes by hepatocyte stimulating factors and other mediators of inflammation. Mol Biol Med 7:147–153, 1990

    PubMed  Google Scholar 

  4. Baumann H, Richards C, Gauldie J: Interaction among hepatocyte-stimulating factors, interleukin-1, and glucocorticoids for regulation of acute phase plasma proteins in human hepatoma (Hep G2) cells. J Immunol 139:4122–4126, 1987

    PubMed  Google Scholar 

  5. Bolyard MG, Lord ST: High-level expression of a functional human fibrinogen gamma chain in Escherichia coli. Gene 66:183–187, 1988

    PubMed  Google Scholar 

  6. Bond JF, Farmer SR: Regulation of tubulin and actin mRNA production in rat brain: expression of a new beta tubulin mRNA with development. Mol Cell Biol 3:1333–1339, 1983

    PubMed  Google Scholar 

  7. Carter DB, Deibel MR, Dunn CJ, Tomich CRC, Laborde AL, Slighton JL, Berger AE, Bienkowski MJ, Sun FF, McEwan RN, Harris PKW, Yem AW, Waszak GA, Chosay JG, Siell LC, Hardee MM, Zuncher-Neely HA, Readon IM, Heinrikson RL, Tewesdell SE, Shelly JA, Eessalu TE, Taylor BM, Tracey DE: Purification, cloning, expression and biological characterization of interleukin-1 receptor antagonist protein. Nature 344:633–638, 1990

    PubMed  Google Scholar 

  8. Chirgwin JM, Rzybyla AE, McDonald RJ, Rutter WJ: Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294–5300, 1979

    PubMed  Google Scholar 

  9. Coceani F, Bishai I, Lees J, Sirko S: Prostaglandin E2 in the pathogenesis of pyrogen fever: Validation of an intermediary role. Adv. Prostaglandin Thromboxane Leukotriene Res 19:394–397, 1989

    Google Scholar 

  10. Conti P Interleukin-1 and interleukin-1 receptor antagonist. Ann Med Internee 142:521–525, 1991

    Google Scholar 

  11. Conti P, Cifone MG, Alesse E, Reale M, Fieschi C and Dinarello CA:In vitro enhanced thromboxane B2 release by polymorphonuclear leukocytes and macrophages after treatment with human recombinant interleukin-1. Prostaglandins 32:111–115, 1986

    PubMed  Google Scholar 

  12. Conti P, Cifone MG, Alesse E, Fieschi C, and Angeletti PU: Augmentation of thromboxane productionin vitro by polymorphonuclears and macrophages exposed to IL-1. Agents and Actions 17:390–391, 1985

    Google Scholar 

  13. Conti P, Dempsey RA: Interleukin 4 and interleukin 1 receptor antagonist down-regulate interleukin 1 and tumor necrosis factor (TNF) generation in macrophages. Int J Immunopathol Pharmacol 2: I-II, 1990

    Google Scholar 

  14. Conti P, Panara MR, Barbacane RC, Placido FC, Bongrazio M, Reale M, Dempsey RA, Fiore S: Blocking the interleukin-1 receptor inhibits leukotriene B4 and prostaglandin E2 generation in human monocyte cultures. Cell Immunol 145:199–209, 1992

    PubMed  Google Scholar 

  15. Conti P, Reale M, Barbacane RC, Bongrazio M, Panara MR, Fiore S, Dempsey R, Borish L: Leukocyte inhibitory factor activates human neutrophils and macrophages to release leukotriene B4 and thromboxanes. Cytokine 2:142–148, 1990

    PubMed  Google Scholar 

  16. Crowl RM, Stoller TJ, Conroy RR, Stoner CR: Induction of phospholipase A2 gene expression in human hepatoma cells by mediators of the acute phase response. J Biol Chem 266:2647–2651, 1991

    PubMed  Google Scholar 

  17. Dinarello CA: Interleukin-1 and the pathogenesis of the acute phase response. J Exp Med 311:1413–1421, 1984

    Google Scholar 

  18. Dinarello CA: Strategies for anti-interleukin-1 therapies. Int J Immunopathol Pharmacol 2:203–211, 1989

    Google Scholar 

  19. Dinarello CA: Induction of acute phase reactants by interleukin-1. Adv Inflamm Res (ed.) G. Weissmann, Raven Press 8:203–225, 1984

    Google Scholar 

  20. Dower SK, Gillis S, Sims JE: The interleukin-1 receptor and post-receptor events. Bomford and Henderson (eds), Interleukin-1, inflammation and disease. Elsevier Science Publishers B.V. pp 63–79, 1989

  21. Dripps DJ, Brandhuber BJ, Thompson RC, Eisenberg SP: Interleukin-1 (IL-1) receptor antogonist binds to the 80-KDa IL-1 receptor but does not initiate IL-1 signal transduction. J Biol Chem 266:10331–10336, 1991

    PubMed  Google Scholar 

  22. Flower RJ, Vane JR: Inhibition of prostaglandin synthesis in brain explants, the anti-pyretic activity of paracetamol. Nature 240:410–411, 1972

    PubMed  Google Scholar 

  23. Ford-Hutchinson AW, Bray MA, Doig MV, Shipley ME, Smith MJH: Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature 286:264–265, 1980

    PubMed  Google Scholar 

  24. Ganapathi MK, Schultz A, Mackiewicz D, Samols S-I, Hu A, Brabenac S, Macintyre S, Kushner I: Heterogenous nature of the acute phase response. Differential regulation of human serum amyloidA, C-reative protein, and other acute phase proteins by cytokines in Hep 3B cells. J Immunol 141:564–569, 1988

    PubMed  Google Scholar 

  25. Gordon AH, Koj A: The acute phase response to injury and infection. Elsevier, Amsterdam, pp 1–339, 1985

    Google Scholar 

  26. Haluska PV, Cook JA, Wise WC: Beneficial effects of UK37248, a thromboxane synthetase inhibitor, in experimental endotoxic shock in the rat. Br J Clin Pharmacol 15:1335–1395, 1983

    Google Scholar 

  27. Hannum CH, Wilcox CJ, Arend WP, Joslin FG, Dripps DJ, Heimdal PL, Armes LG, Sommer A, Eisenberg SP, Thompson RC: Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature 343, 336–340, 1990

    PubMed  Google Scholar 

  28. Kobayashi Y, Sanada JI, Osawa T: Activation of membrane phospholipase A by guinea pig lymphotoxin (GLT). J Immunol 22: 791–794, 1979

    Google Scholar 

  29. Mackiewicz A, Speroff T, Ganapathi MH and Kushner I: Effects of cytokine combinations on acute phase protein production in two human hepatoma cell lines. J Immunol 146:3032–3037, 1991

    PubMed  Google Scholar 

  30. Neta R, Vogel SN, Sipe JD, Wong GG, Nordan RP: Comparison ofin vivo effects of human recombinant IL-1 and human recombinant IL-6 in mice. Lymphokine Res 7:403–407, 1988

    PubMed  Google Scholar 

  31. Okusawa S, Gelfand JA, Ikejima T, Connolly DJ, Dinarello CA: Interleukin-1 induces a shock-like state in rabbits. J Clin Invest 81: 1162–1172, 1988

    PubMed  Google Scholar 

  32. Ramadori G, Sipe JD, Dinarello CA, Mizel SB, Colten HR: Pretranslational modulation of acute phase hepatic protein synthesis by murine recombinant interleukin-1 (IL-1) and purified human IL-1. J Exp Med 162:930–942, 1985

    PubMed  Google Scholar 

  33. Sipe JD: The molecular biology of interleukin-1 and the acute phase response. Adv Intern Med 34:1–15, 1989

    PubMed  Google Scholar 

  34. Sipe JD: Interleukin-1 and regulators of the acute phase response. Lymphokines, 12:87–93, 1985

    Google Scholar 

  35. Sipe JD, Gonnerman WA, Loose LD, Knapschaefer G, Franzblau CJ: Direct binding enzyme-linked immunosorbent assay (ELISA) for serum amyloid A (SAA). Immunol Methods 125:125–135, 1987

    Google Scholar 

  36. Sipe JD, Rokita H, Bartle LM, Loose LD, Neta R: IL-1 receptor antagonist simultaneously inhibits SAA and stimulates fibrinogen synthesisin vivo andin vitro: a proposed mechanism of action. Cytokine 3:497–502, 1991

    Google Scholar 

  37. Spriggs MK, Lioubin PJ, Slack J, Dower SK, Jonas U, Cosman D, Sims JE, Bauer J: Induction of an interleukin-1 receptor (IL-1R) on monocytic cells. J Biol Chem 265:22499–22505, 1990

    PubMed  Google Scholar 

  38. Tatsuta E, Sipe JD, Shirahama T, Skinner M, Cohen AS: Different regulatory mechanism for serum amyloid A and serum amyloid P synthesis by cultured mouse hepatocytes. J Biol Chem 258:5414–5418, 1983

    PubMed  Google Scholar 

  39. Tso JY, Sun X-H, Kao T-H, Reece KS, Wu R: Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. Nucleic Acids Res 13:2485–2490, 1985

    PubMed  Google Scholar 

  40. Yap SH, Moshage HJ, Hazenberg BPC, Rollofs HMJ, Bijzet J, Limburg PC, Aarden LA, Van Rijswijk MM: Tumor necrosis factor (TNF) inhibits interleukin (IL)-1 and/or IL-6 stimulated synthesis of C-reative protein (CRP) and serum amyloid A (SSA) in primary cultures of human hepatocytes. Biochem Bioph Acta 1091:405–410, 1991

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Immunology Division, Institute of Experimental Medicine, University of Chieti Medical School, 66100, Chieti, Italy

    Pio Conti, Renato C. Barbacane & Marcella Reale

  2. Department of Biochemistry, Boston University School of Medicine, 02118, Boston, MA, USA

    Laura Bartle & Jean D. Sipe

Authors
  1. Pio Conti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Laura Bartle
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Renato C. Barbacane
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Marcella Reale
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jean D. Sipe
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Conti, P., Bartle, L., Barbacane, R.C. et al. The down-regulation of IL-6-stimulated fibrinogen steady state mRNA and protein levels by human recombinant IL-1 is not PGE2-dependent: Effects of IL-1 receptor antagonist (IL-1RA). Mol Cell Biochem 142, 171–178 (1995). https://doi.org/10.1007/BF00928938

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00928938

Key Words

Search

Navigation